These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2040364)

  • 1. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
    Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
    Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
    Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splanchnic artery occlusion shock: vinblastine-induced leukopenia reduces tumour necrosis factor and thromboxane A2 formation, and increases survival rate.
    Canale P; Squadrito F; Zingarelli B; Altavilla D; Ioculano M; Campo GM; Caputi AP
    Pharmacol Res; 1993; 27(1):61-71. PubMed ID: 8456059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.
    Sturniolo R; Squadrito F; Altavilla D; Trimarchi GR; Prosdocimi M; Caputi AP
    Circ Shock; 1989 Jul; 28(3):267-77. PubMed ID: 2766481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Campo GM; Arlotta M; Grimaldi S; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):498-504. PubMed ID: 10385251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Minutoli L; Ferlito M; Saitta A; Caputi AP
    Eur J Pharmacol; 1998 Nov; 361(1):101-8. PubMed ID: 9851547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Saitta A; Caputi AP
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1412-7. PubMed ID: 7537468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Canale P; Ioculano M; Campo GM; Ammendolia L; Ferlito M; Zingarelli B; Squadrito G; Saitta A
    Br J Pharmacol; 1994 Dec; 113(4):1153-8. PubMed ID: 7889268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splanchnic artery occlusion shock in the rat: effects of the calcium entry blockers nimodipine and verapamil.
    Sturniolo R; Altavilla D; Berlinghieri MC; Squadrito F; Caputi AP
    Circ Shock; 1988; 24(1):43-53. PubMed ID: 3345594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.
    Squadrito F; Guarini S; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Cucinotta D; Bazzani C; Cainazzo MM; Mioni C; Bertolini A; Caputi AP
    Br J Pharmacol; 1999 Oct; 128(3):816-22. PubMed ID: 10516667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Ammendolia L; Squadrito G; Campo GM; Canale P; Ioculano M; Musolino C; Alonci A; Saitta A; Rossi F; Caputi AP
    Eur J Pharmacol; 1996 Dec; 318(1):153-60. PubMed ID: 9007527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Saitta A; Caputi AP
    Br J Pharmacol; 1999 May; 127(2):482-8. PubMed ID: 10385249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.
    Squadrito F; Altavilla D; Ammendolia L; Squadrito G; Campo GM; Sperandeo A; Canale P; Ioculano M; Saitta A; Caputi AP
    Br J Pharmacol; 1995 Jun; 115(3):395-400. PubMed ID: 7582448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-selectin involvement in the pathogenesis of splanchnic artery occlusion shock.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Ammendolia L; Caputi AP
    Eur J Pharmacol; 1995 Jan; 272(2-3):223-9. PubMed ID: 7536163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of cyclosporin-A in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Squadrito G; Ferlito M; Deodato B; Arlotta M; Minutoli L; Campo GM; Bova A; Quartarone C; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 2000 May; 130(2):339-44. PubMed ID: 10807671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
    J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.